These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15408351)

  • 1. Absorption and excretion of streptomycin para-aminosalicylate.
    ADCOCK JD; STOW RM
    Proc Soc Exp Biol Med; 1949 Nov; 72(2):451-3. PubMed ID: 15408351
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptomycin para-aminosalicylate in the treatment of pulmonary tuberculosis.
    DUNNER E; BROWN WB
    Dis Chest; 1951 Apr; 19(4):438-43. PubMed ID: 14822787
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative in vitro response of tubercle bacillus (H37RV) to dihydrostreptomycin, para-aminosalicylic acid, and dihydrostreptomycin-para-aminosalicylate.
    VENNESLAND K; ALTONA J; BLOCH RG
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):436-8. PubMed ID: 14808284
    [No Abstract]   [Full Text] [Related]  

  • 4. Reaction to streptomycin and to sodium para-aminosalicylate (PAS).
    MCLEOD JA
    N Z Med J; 1955 Oct; 54(303):555-9. PubMed ID: 13288813
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of dihydrostreptomycin para-aminosalicylate on experimental tuberculosis in guinea pigs.
    KARLSON AG; GAINER JH; FELDMAN WH
    Am Rev Tuberc; 1950 Aug; 62(2):149-55. PubMed ID: 15432876
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcium excretion in therapy with antituberculotic drugs].
    LANYI RM
    Z Tuberk; 1952; 101(3-4):190-2. PubMed ID: 13039456
    [No Abstract]   [Full Text] [Related]  

  • 7. The absorption, distribution, excretion and fate of para-aminosalicylic acid.
    WAY EL; SMITH PK
    J Pharmacol Exp Ther; 1948 Jul; 93(3):368-82. PubMed ID: 18882143
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observations on absorption and excretion of para-aminosalicylic acid administered by various routes].
    IZZO RA; MARENZI AD; GOMEZ CJ; ROSS S
    Publ B Aires Cent Investig; 1954-1955; 18():9-17. PubMed ID: 13336211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Organotropism and metabolic actions of some antitubercular chemoantibiotics in the lung. I. Histotropism, cytotropism and metabolic transformations of streptomycin, para-aminosalicylic acid, isoniazid and cycloserine in pulmonary tissues].
    MASCHERPA P
    G Ital Tuberc Mal Torace; 1960; 14():255-9. PubMed ID: 13767726
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antituberculous effects of streptomycin p-aminosalicylate].
    LEVADITI C; VAISMAN A; CHAIGNEAU H; HENRY-EVENO J
    Ann Inst Pasteur (Paris); 1950 Dec; 79(6):886-90. PubMed ID: 14811116
    [No Abstract]   [Full Text] [Related]  

  • 11. SEQUENTIAL use of paired combinations of isoniazid, streptomycin, para-aminosalicylic acid, and pyrazinamide. A United States Public Health Service tuberculosis therapy trial.
    Am Rev Respir Dis; 1959 Nov; 80():627-40. PubMed ID: 13856609
    [No Abstract]   [Full Text] [Related]  

  • 12. [Absorption, circulation in the blood, distribution in various organs, and excretion of paraaminosalicylic acid].
    KOZLOVSKAIA OI
    Farmakol Toksikol; 1956; 19(2):42-5. PubMed ID: 13318024
    [No Abstract]   [Full Text] [Related]  

  • 13. [Formation and excretion of RHO-aminosalicylic acid metabolites].
    LAUENER H; HODLER J; FAVEZ G; DETTWILER E; HADORN L
    Klin Wochenschr; 1957 Apr; 35(8):393-401. PubMed ID: 13450229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
    Janowiec M; Zwolska-Kwiek Z; Wiśniewska A; Wróblewska H
    Pneumonol Pol; 1977 Jun; 45(6):425-30. PubMed ID: 406600
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance of phenyl para-aminosalicylate, a comparative study.
    COHEN SS; YUE WY; TSAI SH
    Dis Chest; 1962 Oct; 42():379-83. PubMed ID: 14022105
    [No Abstract]   [Full Text] [Related]  

  • 16. The cause of hypokalaemia (hypopotassaemia) following para-aminosalicylate therapy.
    CAMPBELL AH; NEUFELD OE
    Med J Aust; 1951 May; 1(20):725-7. PubMed ID: 14852176
    [No Abstract]   [Full Text] [Related]  

  • 17. [The action of ethamide on the excretion of p-aminosalicylic acid by the kidneys].
    SNEGIREV EA
    Probl Tuberk; 1962; 40(4)():87-92. PubMed ID: 13914568
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circulation of sodium para-aminosalicylate in man and in animal].
    PELLERAT J; MARAL R; MURAT M; BLANDIN A; BRUGIRARD M
    Ann Biol Clin (Paris); 1950; 8(4):485-93. PubMed ID: 14790337
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of potassium para-aminosalicylate (KPAS).
    MOLTHAN L; COHEN RV; ZARAFONETIS CJ
    Am Rev Tuberc; 1955 Feb; 71(2):220-7. PubMed ID: 14350181
    [No Abstract]   [Full Text] [Related]  

  • 20. An evaluation of potassium para-aminosalicylate.
    CHERNISH SM; PECK FB
    Antibiotic Med Clin Ther (New York); 1955 Jul; 1(7):377-81. PubMed ID: 13239091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.